PANEL DISCUSSION. 3. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. ASSAY OF ANTI-ANXIETY DRUGS BY QUANTITATIVE ELECTROENCEPHALOGRAPHY.
D000438:Alcohols; D000661:Amphetamine; D014151:Anti-Anxiety Agents; D001007:Anxiety; D001008:Anxiety Disorders; D035843:Biomedical Research; D002707:Chlordiazepoxide; D004569:Electroencephalography; D000431:Ethanol; D006993:Hypnotics and Sedatives; D008620:Meprobamate; D010600:Pharmacology; D010634:Phenobarbital; D010919:Placebos; D012890:Sleep; D014149:Tranquilizing Agents
D000438:Alcohols; D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D010919:Placebos; D014149:Tranquilizing Agents; D000431:Ethanol; D002707:Chlordiazepoxide; D008620:Meprobamate; D000661:Amphetamine; D010634:Phenobarbital
ALCOHOL, ETHYL; AMPHETAMINE; CHLORDIAZEPOXIDE; CLINICAL RESEARCH; ELECTROENCEPHALOGRAPHY; MEPROBAMATE; PHARMACOLOGY; PHENOBARBITAL; PLACEBOS; SLEEP